Skip to main content
Equibles

Centerpoint Advisors, LLC

Position in GERN — Geron Corp

CIK 1733788 NEEDHAM, MA
Back to GERN Full portfolio

Position in GERN

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$384
-$63 QoQ
Shares Held
300
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#253
of 260 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GERN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Centerpoint Advisors, LLC holds $114,760 across 8 Biotechnology names. GERN ranks #4 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 87 $43,215
2 HALO
Halozyme Therapeutics, Inc.
 545 $42,657
3 ARGX
Argenx SE
 30 $27,833
4 GERN
Geron Corp
This page 		300 $384
5 NMRA
Neumora Therapeutics, Inc.
 220 $374
6 YARW
Yarrow Bioscience, Inc.
 7 $227
7 RNA
Atrium Therapeutics, Inc.
 5 $67
8 PHVS
Pharvaris N.V.
 100 $3

All Filings in GERN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $384 300
2026-03-31 $447 300
2025-12-31 $396 300
2025-09-30 $411 300
2025-06-30 $423 300
2025-03-31 $477 300
2024-12-31 $1,062 300
2024-09-30 $1 300
2024-06-30 $1 300
2024-03-31 $990 300
2023-12-31 $1 300
2023-09-30 $1 300
2023-06-30 $963 300
2023-03-31 $1 300
2022-12-31 $5,566 2,300
2022-09-30 $1,404 600
2022-06-30 $465 300
2022-03-31 $408 300
2021-12-31 $366 300
2021-09-30 $411 300
2021-06-30 $423 300
2021-03-31 $474 300
2020-12-31 $954 600
2020-09-30 $1,044 600
2020-06-30 $1,308 600